title: Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes.
abstract: Painful diabetic neuropathy (PDN) is a common, yet devastating complication of type 2 diabetes. At this time, there is no objective test for diagnosing PDN. In the current study, we measured the peptidergic intraepidermal nerve fiber densities (IENFD) from hind paws of the db/db mouse, an animal model for type 2 diabetes, during the period of mechanical allodynia from 6 to 12 weeks of age. Intraepidermal nerve fibers (IENF) of the hind footpads were identified by protein gene product (PGP) 9.5 immunohistochemistry. The peptidergic IENF were determined by double immunofluorescence using anti-PGP9.5 and antibodies against tropomyosin-receptor-kinase (Trk) A. We observed a significant increase in PGP9.5-positive IENFD at 8 and 10 weeks of age. Similarly, Trk A-positive peptidergic IENF, which also express substance P and calcitonin gene related peptide in db/db mice, were observed to be elevated from 1.5 to 2 fold over controls. This upregulation ended at 16 weeks of age, in accordance with the reduction of mechanical allodynia. Anti-NGF treatment significantly inhibited the upregulation of peptidergic IENFD during the period of mechanical allodynia, suggesting that increased neurotrophism may mediate this phenomenon. In addition, SB203580, an inhibitor of p38, blocked the increase in peptidergic IENFD in db/db mice. The current results suggest that peptidergic IENFD could be a potential diagnostic indicator for PDN in type 2 diabetes. Furthermore, the inhibition of NGF-p38 signaling could be a potential therapeutic strategy for treating this painful condition.
authors.affiliation: Department of Neurology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA. chengt@umich.edu
authors.forename: Hsinlin T
authors.initials: HT
authors.lastname: Cheng
authors.forename: Jacqueline R
authors.initials: JR
authors.lastname: Dauch
authors.forename: John M
authors.initials: JM
authors.lastname: Hayes
authors.forename: Brandon M
authors.initials: BM
authors.lastname: Yanik
authors.forename: Eva L
authors.initials: EL
authors.lastname: Feldman
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D003929:Diabetic Neuropathies / Q000378:metabolism*; D004195:Disease Models, Animal; D006930:Hyperalgesia / Q000378:metabolism; D008297:Male; D051379:Mice; D009412:Nerve Fibers / Q000378:metabolism*; D020932:Nerve Growth Factor / Q000378:metabolism*; D009765:Obesity / Q000378:metabolism; D010812:Physical Stimulation; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D020932:Nerve Growth Factor